Drug – Gene Annotation
Studies show that over half of all primary care patients are exposed to drugs that have known drug-gene interactions; that 7% of FDA-approved medications and 18% of the 4 billion prescriptions written in the United States per year are affected by actionable drug-gene interactions; and that nearly all individuals (98%) have at least one known, actionable genomic variant that affects medications.
Our Drug-Gene Annotation app identifies genetic variants that affect drug metabolism, efficacy, and safety; and reports actual and potential drug interactions. Actual interactions are those where a genetic variant affects a currently active medication. Potential interactions are those where a genetic variant is present that can affect a medication, should the patient be exposed to it in the future.
- Compares a patient’s medication list against their genomic data and reports identified interactions.
- Preemptively scans a patient’s genomic data for variants that affect drug metabolism/efficacy/safety.
- Implements Clinical Pharmacogenetics Implementation Consortium (CPIC) Level A (i.e. actionable) drug-gene interaction findings.